145 related articles for article (PubMed ID: 18782348)
21. Glycogen synthase kinase 3 activity mediates neuronal pentraxin 1 expression and cell death induced by potassium deprivation in cerebellar granule cells.
Enguita M; DeGregorio-Rocasolano N; Abad A; Trullas R
Mol Pharmacol; 2005 Apr; 67(4):1237-46. PubMed ID: 15630079
[TBL] [Abstract][Full Text] [Related]
22. Glycogen content and contraction regulate glycogen synthase phosphorylation and affinity for UDP-glucose in rat skeletal muscles.
Lai YC; Stuenaes JT; Kuo CH; Jensen J
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1622-9. PubMed ID: 17878227
[TBL] [Abstract][Full Text] [Related]
23. Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts.
Gross ER; Hsu AK; Gross GJ
Circ Res; 2004 Apr; 94(7):960-6. PubMed ID: 14976126
[TBL] [Abstract][Full Text] [Related]
24. The influence of glycogen synthase kinase 3 in limiting cell addition in the mammalian ear.
Lu Z; Corwin JT
Dev Neurobiol; 2008 Jul; 68(8):1059-75. PubMed ID: 18470861
[TBL] [Abstract][Full Text] [Related]
25. Development of a cellular tau enzyme-linked immunosorbent assay method for screening GSK-3β inhibitors.
Cho GW; Noh MY; Kang BY; Ku IW; Park J; Hong YH; Kim MH; Kim SH
Assay Drug Dev Technol; 2011 Oct; 9(5):503-13. PubMed ID: 21561378
[TBL] [Abstract][Full Text] [Related]
26. Lithium ions increase hepatic glycogen synthase stability through a proteasome-related mechanism.
Fernández-Novell JM; Rodríguez-Gil JE; Barberà A; Guinovart JJ
Arch Biochem Biophys; 2007 Jan; 457(1):29-34. PubMed ID: 17125726
[TBL] [Abstract][Full Text] [Related]
27. Glycogen synthase kinase 3 has a limited role in cell cycle regulation of cyclin D1 levels.
Yang K; Guo Y; Stacey WC; Harwalkar J; Fretthold J; Hitomi M; Stacey DW
BMC Cell Biol; 2006 Aug; 7():33. PubMed ID: 16942622
[TBL] [Abstract][Full Text] [Related]
28. Effects of glycogen synthase kinase 3beta and cyclin-dependent kinase 5 inhibitors on morphine-induced analgesia and tolerance in rats.
Parkitna JR; Obara I; Wawrzczak-Bargiela A; Makuch W; Przewlocka B; Przewlocki R
J Pharmacol Exp Ther; 2006 Nov; 319(2):832-9. PubMed ID: 16902054
[TBL] [Abstract][Full Text] [Related]
29. Phosphatidylinositol 3-kinase and glycogen synthase kinase 3 regulate estrogen receptor-mediated transcription in neuronal cells.
Mendez P; Garcia-Segura LM
Endocrinology; 2006 Jun; 147(6):3027-39. PubMed ID: 16497810
[TBL] [Abstract][Full Text] [Related]
30. Bile acids enhance the activity of the insulin receptor and glycogen synthase in primary rodent hepatocytes.
Han SI; Studer E; Gupta S; Fang Y; Qiao L; Li W; Grant S; Hylemon PB; Dent P
Hepatology; 2004 Feb; 39(2):456-63. PubMed ID: 14767998
[TBL] [Abstract][Full Text] [Related]
31. Regulation of Akt mRNA and protein levels by glycogen synthase kinase-3beta in adrenal chromaffin cells: effects of LiCl and SB216763.
Nemoto T; Kanai T; Yanagita T; Satoh S; Maruta T; Yoshikawa N; Kobayashi H; Wada A
Eur J Pharmacol; 2008 May; 586(1-3):82-9. PubMed ID: 18395711
[TBL] [Abstract][Full Text] [Related]
32. Cocaine-induced hyperactivity and sensitization are dependent on GSK3.
Miller JS; Tallarida RJ; Unterwald EM
Neuropharmacology; 2009 Jun; 56(8):1116-23. PubMed ID: 19328817
[TBL] [Abstract][Full Text] [Related]
33. Independent signal-transduction pathways for vanadate and for insulin in the activation of glycogen synthase and glycogenesis in rat adipocytes.
Sekar N; Li J; He Z; Gefel D; Shechter Y
Endocrinology; 1999 Mar; 140(3):1125-31. PubMed ID: 10067835
[TBL] [Abstract][Full Text] [Related]
34. An expanding GSK3 network: implications for aging research.
Souder DC; Anderson RM
Geroscience; 2019 Aug; 41(4):369-382. PubMed ID: 31313216
[TBL] [Abstract][Full Text] [Related]
35. Anti-obesity effects of 3-hydroxychromone derivative, a novel small-molecule inhibitor of glycogen synthase kinase-3.
Lee S; Yang WK; Song JH; Ra YM; Jeong JH; Choe W; Kang I; Kim SS; Ha J
Biochem Pharmacol; 2013 Apr; 85(7):965-76. PubMed ID: 23337568
[TBL] [Abstract][Full Text] [Related]
36. Glycogen synthase kinase 3 activity during development of bone marrow-derived dendritic cells (DCs) essential for the DC function to induce T helper 2 polarization.
Ono T; Yanagawa Y; Iwabuchi K; Nonomura K; Onoé K
Immunology; 2007 Oct; 122(2):189-98. PubMed ID: 17490435
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of GSK3beta is a common event in neuroprotection by different survival factors.
Chin PC; Majdzadeh N; D'Mello SR
Brain Res Mol Brain Res; 2005 Jun; 137(1-2):193-201. PubMed ID: 15950778
[TBL] [Abstract][Full Text] [Related]
38. Repression of GSK3 restores NK cell cytotoxicity in AML patients.
Parameswaran R; Ramakrishnan P; Moreton SA; Xia Z; Hou Y; Lee DA; Gupta K; deLima M; Beck RC; Wald DN
Nat Commun; 2016 Apr; 7():11154. PubMed ID: 27040177
[TBL] [Abstract][Full Text] [Related]
39. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.
Dokken BB; Sloniger JA; Henriksen EJ
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078
[TBL] [Abstract][Full Text] [Related]
40. Inhibiting glycogen synthase kinase 3beta in sepsis.
Dugo L; Collin M; Allen DA; Patel NS; Bauer I; Mervaala E; Louhelainen M; Foster SJ; Yaqoob MM; Thiemermann C
Novartis Found Symp; 2007; 280():128-42; discussion 142-6, 160-4. PubMed ID: 17380792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
